Latest Ratios: P/E Ratio 1.2x · EV/EBITDA 1.4x · ROE 26.9%. (2011–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $145M | $272M | $141M | $103M | $114M | $347M | $285M | $151M | $108M | $119M | $112M |
| Enterprise Value | $165M | $293M | $194M | $149M | $147M | $221M | $277M | $145M | $118M | $128M | $171M |
| P/E Ratio → | 1.24 | 5.55 | — | 20.74 | — | 2.35 | 3.68 | 5.75 | 120.55 | 6.81 | — |
| P/S Ratio | 0.00 | 7.79 | 30.07 | 15.66 | 33.01 | 235.59 | 156.37 | 101.03 | 66.52 | 140.12 | 151.53 |
| P/B Ratio | 0.77 | 1.32 | 0.89 | 0.51 | 0.54 | 0.95 | 0.95 | 0.76 | 0.55 | 0.58 | 0.58 |
| P/FCF | — | 7.92 | 59.31 | — | — | — | 3.73 | — | 11.24 | 2.11 | — |
| P/OCF | 4.21 | 7.92 | 59.31 | — | — | — | 3.73 | — | 11.24 | 2.11 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 8.38 | 41.46 | 22.57 | 42.64 | 150.33 | 151.77 | 96.98 | 72.86 | 150.14 | 231.91 |
| EV / EBITDA | 1.39 | 5.45 | — | 29.38 | — | 1.50 | 3.67 | 6.06 | 132.19 | 7.29 | — |
| EV / EBIT | 3.08 | 5.45 | — | 29.38 | — | 1.50 | 3.67 | 6.06 | 132.19 | 7.29 | — |
| EV / FCF | — | 8.52 | 81.77 | — | — | — | 3.62 | — | 12.31 | 2.26 | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | 100.0% | -520.9% | 306.9% | -3439.0% | 10727.2% | 4902.5% | 2429.6% | 1.0% | 2554.6% | -9430.5% |
| Operating Margin | 153.9% | 153.9% | -815.8% | 76.8% | -3824.4% | 9999.2% | 4130.1% | 1601.5% | 55.1% | 2060.1% | -10185.6% |
| Net Profit Margin | 139.9% | 139.9% | -815.8% | 76.8% | -3824.4% | 9999.2% | 4130.1% | 1601.5% | 55.1% | 2060.1% | -10185.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 26.9% | 26.9% | -21.1% | 2.5% | -46.0% | 44.1% | 30.0% | 12.1% | 0.4% | 8.9% | -39.0% |
| ROA | 19.2% | 19.2% | -15.0% | 1.8% | -35.4% | 31.3% | 19.6% | 7.7% | 0.3% | 5.1% | -24.9% |
| ROIC | 18.4% | 18.4% | -12.4% | 1.5% | -41.1% | 41.4% | 23.2% | 9.0% | 0.3% | 5.7% | — |
| ROCE | 21.2% | 21.2% | -15.0% | 1.8% | -36.7% | 37.9% | 26.0% | 10.1% | 0.4% | 7.3% | -27.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.34 | 0.34 | 0.46 | 0.36 | 0.35 | 0.20 | 0.12 | 0.19 | 0.20 | 0.33 | 0.35 |
| Debt / EBITDA | 1.30 | 1.30 | — | 14.55 | — | 0.50 | 0.50 | 1.62 | 43.10 | 3.89 | — |
| Net Debt / Equity | — | 0.10 | 0.34 | 0.22 | 0.16 | -0.34 | -0.03 | -0.03 | 0.05 | 0.04 | 0.31 |
| Net Debt / EBITDA | 0.39 | 0.39 | — | 8.99 | — | -0.85 | -0.11 | -0.25 | 11.49 | 0.49 | — |
| Debt / FCF | — | 0.60 | 22.46 | — | — | — | -0.11 | — | 1.07 | 0.15 | — |
| Interest Coverage | 10.56 | 10.56 | -7.87 | 1.04 | -27.28 | 212.06 | 33.52 | 10.10 | 0.20 | 3.74 | -15.85 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 52.79 | 52.79 | 26.81 | 58.76 | 41.40 | 8.25 | 0.34 | 0.97 | 0.33 | 0.36 | 0.28 |
| Quick Ratio | 52.79 | 52.79 | 26.81 | 58.76 | 41.40 | 8.25 | 0.34 | 0.97 | 0.33 | 0.36 | 0.28 |
| Cash Ratio | 52.79 | 52.79 | 25.78 | 56.49 | 39.92 | 8.12 | 0.33 | 0.93 | 0.30 | 0.35 | 0.27 |
| Asset Turnover | — | 0.13 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | 62.58 | 24.45 | 81.01 | 541.68 | 203.99 | 85.39 | 620.48 | 273.69 | 46.08 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 7.6% | 4.4% | 0.1% | 0.1% | 23.3% | 29.9% | 5.1% | 2.3% | — | — | 0.8% |
| Payout Ratio | 24.5% | 24.5% | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 80.8% | 18.0% | — | 4.8% | — | 42.6% | 27.2% | 17.4% | 0.8% | 14.7% | — |
| FCF Yield | — | 12.6% | 1.7% | — | — | — | 26.8% | — | 8.9% | 47.4% | — |
| Buyback Yield | 0.0% | 0.0% | 6.7% | 13.7% | 18.8% | 0.0% | 3.6% | 9.8% | 9.5% | 4.1% | 0.0% |
| Total Shareholder Yield | 7.6% | 4.4% | 6.8% | 13.9% | 42.1% | 29.9% | 8.8% | 12.1% | 9.5% | 4.1% | 0.8% |
| Shares Outstanding | — | $29M | $24M | $26M | $30M | $27M | $22M | $23M | $21M | $22M | $22M |
Includes 30+ ratios · 15 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NSLR stock.
Neostellar Capital Corp.'s current P/E ratio is 1.2x. The historical average is 21.5x.
Neostellar Capital Corp.'s current EV/EBITDA is 1.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 8.7x.
Neostellar Capital Corp.'s return on equity (ROE) is 26.9%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 1.1%.
Based on historical data, Neostellar Capital Corp. is trading at a P/E of 1.2x. Compare with industry peers and growth rates for a complete picture.
Neostellar Capital Corp.'s current dividend yield is 7.61% with a payout ratio of 24.5%.
Neostellar Capital Corp. has 100.0% gross margin and 153.9% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Neostellar Capital Corp.'s Debt/EBITDA ratio is 1.3x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Earnings dependent on episodic gains
Metrics are mathematically derived from official filings.
Book Premium Unbacked By Returns
Neostellar trades at 1.52x book value, roughly double the 0.70x median of the cited BDC peer set, while the 6.38x trailing P/E rests on episodic gains rather than spread income, suggesting the market may not yet have priced the balance sheet's earnings quality problem.
Against CSWC at 1.46x book and sub-1.0x multiples for GSBD, GAIN, OXLC and TPVG, Neostellar's 1.52x P/B sits at the top of the group despite nine of ten quarters of negative net interest income, which appears difficult to justify as a franchise premium. The 2.40x forward P/E implies the market expects the 2026Q1-style gain to repeat, but if normalized ROTCE is closer to the negative-to-modest ROE readings outside that quarter, the multiple may instead reflect an untested book value. The 2026Q2 P/B and tangible book figures are recorded as placeholders and should be treated as data unavailable, so current valuation rests on stale fourth-quarter inputs.
Fee Spikes Mask Weak DuPont Drivers
Neostellar's ROE ranged from -11.5% in 2024Q1 to 54.9% in 2026Q1, a spread driven almost entirely by fee spikes rather than asset productivity, since ROA never exceeded 43.9% and turned negative in six of the ten reported quarters, per the company's quarterly ratio disclosures.
The DuPont decomposition points to non-interest income, not NIM or utilization, as the sole profitability engine: fee income reached 94.4% of revenue in 2026Q2 and 99.7% in 2025Q2, while NIM remained negative or near-zero throughout, meaning the spread business appears to dilute rather than add to returns. Equity-to-assets expanded from 0.67 to 0.85 over the window, so rising leverage mechanically amplified ROE in the gain quarter even as underlying asset returns stayed depressed, a pattern that would reverse if those gains do not recur. Profitability quality therefore looks weak despite the headline ROE print, and investors should monitor whether any quarter produces positive ROE without a large non-interest income contribution.
Negative Carry Undermines Core Spread
NIM was negative in nine of ten quarters, bottoming at -0.5% in 2025Q1 and only reaching 0.1% in 2024Q1, indicating funding costs continue to exceed asset yields across the cycle, as reported in Neostellar's quarterly ratio table.
Persistently negative NIM means the traditional banking model contributes nothing to earnings, which is consistent with the nine consecutive quarters of negative net interest income identified in the income statement review, and it implies any improvement would require either repricing assets or reducing funding cost, neither of which is visible in the data. The efficiency ratio is too erratic to signal operating leverage, ranging from 2.3% to -95.7% and diverging from reported operating results in both 2025Q1 and 2026Q1, so it should not be read as evidence of cost discipline. The negative carry appears structural rather than cyclical at this stage and warrants investigation into the composition of the funding base.
Capital Ratio Inflated By Markups
Neostellar's equity-to-assets ratio climbed from 0.67 in 2024Q3 to 0.85 in 2026Q2, the highest reading in the period, though the increase coincides with the $155.6M gain recognized in 2026Q1 rather than retained earnings, according to the company's reported balance sheets.
Reported CET1, Tier 1 and total capital ratios are not disclosed in the supplied data, so regulatory headroom and capacity for capital return cannot be assessed directly; only the equity-to-assets proxy is available, and it should not be read as equivalent to a regulatory capital ratio. The apparent strengthening in the proxy appears to be a mark-to-market outcome rather than accumulated capital generation, which matters because a reversal in the underlying valuations would erode the same cushion that currently supports the 3.8% indicated yield. Given that dividends have at times exceeded operating cash flow, investors should monitor whether capital return is being funded from the balance sheet rather than from internally generated capital.
Reserve Reversal Leaves Credit Untested
Loan loss provisions stood at zero for eight consecutive quarters before a $1.1M reversal in 2026Q2, meaning no credit costs have been absorbed into earnings during the period, as disclosed in Neostellar's income statement and cash flow filings.
With provisions effectively dormant and the loan-to-deposit ratio undisclosed, the reserve level cannot be evaluated against the loan book, so any statement about adequacy or coverage would be inference rather than observation; NPL and coverage ratios are data unavailable here. The 2026Q2 provision reversal adds to reported income without any demonstrated improvement in underlying credit performance, which slightly flatters the period's profitability comparison. Asset quality therefore remains an open question rather than a confirmed strength, and investors should treat the absence of credit costs as a lack of evidence rather than evidence of low risk.
P/E Obscures Earnings Quality
The 6.38x trailing and 2.40x forward P/E are the most misapplied metrics for Neostellar because they capitalize episodic gains, including the 2026Q1 result, while excluding the six loss-making quarters around it, per the company's reported earnings history.
Because provisions were zero for eight quarters and non-interest income supplied 94.4% of revenue in 2026Q2, the earnings denominator swings on transaction outcomes rather than on repeatable spread or fee economics, so any P/E multiple built on it is unstable and potentially misleading in both directions. The appropriate alternative is a P/B or P/TBV multiple assessed alongside normalized ROTCE excluding non-recurring gains, which would likely show the 1.52x book premium against the BDC peer set as less attractive than the headline P/E suggests. Analysts should also avoid leaning on the efficiency ratio and equity-to-assets figures for 2026Q2, which appear to be reporting artifacts and are best treated as data unavailable.